OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation or exhaustion of CD8+ T cells in patients with COVID-19
Min‐Seok Rha, Eui‐Cheol Shin
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2325-2333
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 321

Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Alba Grifoni, Tonino Alonzi, Galit Alter, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49

Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challenge
Matthew L. Coates, Nathan Richoz, Zewen Kelvin Tuong, et al.
Nature Immunology (2025) Vol. 26, Iss. 2, pp. 215-229
Open Access | Times Cited: 1

Impaired function and delayed regeneration of dendritic cells in COVID-19
Elena Winheim, Linus Rinke, Konstantin Lutz, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 10, pp. e1009742-e1009742
Open Access | Times Cited: 72

Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+β7 integrin+ T cells and anti-SARS-CoV-2 IgA response
André Santa Cruz, Ana Mendes‐Frias, Marne Azarias-da-Silva, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31

Beyond Acute COVID-19: A Review of Long-term Cardiovascular Outcomes
Parinaz Parhizgar, Nima Yazdankhah, Anna Rzepka, et al.
Canadian Journal of Cardiology (2023) Vol. 39, Iss. 6, pp. 726-740
Open Access | Times Cited: 27

The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 21

Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
Chapin S. Korosec, Suzan Farhang‐Sardroodi, David W. Dick, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34

Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
Murad Alahdal, Eyad Elkord
Clinical Immunology (2022) Vol. 245, pp. 109177-109177
Open Access | Times Cited: 28

SARS-CoV-2 as an Oncolytic Virus Following Reactivation of the Immune System: A Review
Joao P. Bounassar-Filho, Laura Boeckler-Troncoso, Jocelyne Cajigas-Gonzalez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2326-2326
Open Access | Times Cited: 19

From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
Ganggang Miao, Zhiqiang Chen, Hengsong Cao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114208-114208
Open Access | Times Cited: 17

The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects
Wanchen Song, Zhongbiao Fang, Feike Ma, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 16

Immunological Similarities and Differences between Post-COVID-19 Lung Sequelae and Idiopathic Pulmonary Fibrosis
Sara Gangi, Laura Bergantini, Paolo Cameli, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 630-630
Open Access | Times Cited: 5

Association of Respiratory Infections with the Incidence and treatment efficacy in Kawasaki disease
Soshi Hachisuka, Taito Kitano, Daisuke Kitagawa, et al.
Diagnostic Microbiology and Infectious Disease (2025) Vol. 111, Iss. 3, pp. 116688-116688
Closed Access

Longitudinal Follow‐Up of the Specific Antibody Response to SARS‐CoV‐2 Vaccination in Colombia
Myriam Arévalo‐Herrera, Bladimiro Rincón‐Orozco, John Mario González‐Escobar, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access

Altered immune surveillance of B and T cells in patients with persistent residual lung abnormalities 12 months after severe COVID-19
Julio Flores‐González, Ivette Buendía-Roldán, Fernanda Téllez-Quijada, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access

Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses
Chiara Venegoni, Davide Raineri, Camilla Barbero Mazzucca, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114103-114103
Closed Access

Dissecting the COVID‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARSCoV‐2 Structural Proteins
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, et al.
Journal of Molecular Recognition (2025) Vol. 38, Iss. 2
Closed Access

Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity
Njinju Asaba Clinton, Razieh Bitazar, Patrick Labonté, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0309880-e0309880
Open Access

Characterization of canine tumor-infiltrating leukocyte transcriptomic signatures reveals conserved expression patterns with human osteosarcoma
Dylan T. Ammons, R. Adam Harris, Lyndah Chow, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access

Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

Page 1 - Next Page

Scroll to top